BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Goodman J, Cowan KJ, Golob M, Karlsson L, Kunz U, Nelson R, Ulrichts H, Stevenson L, Terry L, Timmerman P. Update to the European Bioanalysis Forum recommendation on biomarkers assays; bringing context of use into practice. Bioanalysis 2020;12:1427-37. [PMID: 33025797 DOI: 10.4155/bio-2020-0243] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Laurén A, Braun M, Cazzin C, Colleti K, Cox C, Dietz L, Emrich T, Geddes K, Herr K, Iles T, Rogue A, Verlinden Y, Timmerman P. Quantitative polymerase chain reaction in the bioanalytical laboratory and technical and scientific considerations for nonclinical and clinical assay characterization, validation and sample analysis. Bioanalysis 2022. [PMID: 36125042 DOI: 10.4155/bio-2022-0170] [Reference Citation Analysis]
2 J Cowan K, Golob M, Goodman J, Laurén A, Andersen L, Decker P, Dejager L, Fjording MS, Groenen P, Jasnowski R, Justies N, Kimberg M, Kunz U, Lawrence J, Richter M, Sordé L, Trigt RV, Vermet L, Vitaliti A, Wright M, Timmerman P. Biomarker context-of-use: how organizational design can impact the implementation of the appropriate biomarker assay strategy. Bioanalysis 2022. [PMID: 35904153 DOI: 10.4155/bio-2022-0143] [Reference Citation Analysis]
3 Hays A, Amaravadi L, Fernandez-Metzler C, King L, Mathews J, Ni Y, Quadrini K, Tinder C, Vazvaei F, Zeng J. Is Incurred Sample Reanalysis (ISR) Applicable in Biomarker Assays? AAPS J 2022;24:65. [PMID: 35511303 DOI: 10.1208/s12248-022-00708-y] [Reference Citation Analysis]
4 Mathews J, Amaravadi L, Eck S, Stevenson L, Wang YC, Devanarayan V, Allinson J, Lundsten K, Gunsior M, Ni YG, Pepin M, Gagnon A, Sheldon C, Trampont PC, Litwin V. Best practices for the development and fit-for-purpose validation of biomarker methods: a conference report. AAPS Open 2022;8. [DOI: 10.1186/s41120-021-00050-1] [Reference Citation Analysis]
5 Laurén A, Braun M, Byrne P, Cazzin C, Colletti K, Cox C, Dietz L, Emrich T, Geddes K, Herr K, Iles T, Rogue A, Verlinden Y, Timmerman P. Applying context of use to quantitative polymerase chain reaction method validation and analysis: a recommendation from the European Bioanalysis Forum. Bioanalysis 2021;13:1723-9. [PMID: 34708666 DOI: 10.4155/bio-2021-0218] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Yuill D, Rospo CC, Tadema H, Louber J, Post S. Effectively utilizing the Sponsor Contract Research Organization interaction for successful implementation of critical flow cytometry in the clinic. Bioanalysis 2021;13:1617-25. [PMID: 34601974 DOI: 10.4155/bio-2021-0159] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Timmerman P, Barfield M, Cowan K, Golob M, Goodman J, Kunz U, Laurén A, Love I, Nelson R, Staack RF, Stanta J, van de Merbel N, Wilson A. Recommendations and discussion points on immunogenicity, biomarkers, automation/technology and protein-MS from the 2021 European Bioanalysis Forum Focus Workshops. Bioanalysis 2021;13:1459-65. [PMID: 34605275 DOI: 10.4155/bio-2021-0200] [Cited by in F6Publishing: 2] [Reference Citation Analysis]